EEExcelerate Energy, Inc.
The schedule
- Thu15Oct
Mid-quarter operational update on FSRU utilization and winter chartering rates as Northern Hemisphere heating demand peaks.
- Sun7Feb
Q3 results will test Excelerate's ability to translate 37%+ revenue growth into actual net income and free cash flow.
- Sun9May
Crucial end-of-year print providing initial 2027 guidance on charter rates, CapEx, and long-term terminal expansions.
- Sun8Aug
First-quarter results to evaluate the pace of spring global LNG restocking and FSRU downtime/maintenance schedules.
Past
- Sun9Aug
Excelerate Energy reports Q2 results with shares trading near 52-week highs and deeply overbought (RSI at 71.1).
- Wed25Feb
Actual outcome: Bull · $40.36 at outcome
Excelerate Energy met Q4 EPS estimates exactly at $0.29, but reported record full-year results for 2025 with $167 million in net income alongside a new 2026 outlook. The stock moved higher because this record annual profitability and confident forward guidance signaled sustained operational momentum, overshadowing the merely in-line quarterly earnings. Furthermore, news of fresh institutional backing from Amitell Capital reinforced investor confidence in the company's growth trajectory.
Excelerate Energy met Q4 EPS estimates exactly at $0.29, but reported record full-year results for 2025 with $167 million in net income alongside a new 2026 outlook. The stock moved higher because this record annual profitability and confident forward guidance signaled sustained operational momentum, overshadowing the merely in-line quarterly earnings. Furthermore, news of fresh institutional backing from Amitell Capital reinforced investor confidence in the company's growth trajectory.
Scouting Reports
Weekly Playbook: Pricing the Regional Bank M&A Wave (CFFN, BVFL, SMBC)
Oct 11, 2026
The Banking theme just spiked 12 spots on the Scouter board, driven by a surge in investment banking fees. But those advisory fees aren't just coming from mega-cap tech buyouts—they are being minted i
Read more →
Weekly Playbook: Pricing the Healthcare Gauntlet (ABEO, LFVN, KROS)
Oct 5, 2026
The healthcare and biotech sectors are defined by their bottlenecks. Whether a company is waiting on federal guidance or fighting to clear a clinical hurdle, the market brutally penalizes any friction
Read more →
Weekly Playbook: Pricing the Smart Logistics Cycle (ORCL, ANDE, GTES)
Sep 27, 2026
The narrative around ORCL has primarily centered on cloud infrastructure, but the next leg of growth relies on routing physical goods. Artificial intelligence is moving from the data center to the loa
Read more →